Skip to main content
Clinical Trials/CTRI/2021/05/033394
CTRI/2021/05/033394Not yet recruitingPhase 2

TILITY OF INDIVIDUALIZED HOMOEOPATHIC TREATMENTBASED ON ALTERNATING SYMPTOMS OF THE PATIENTS BYUSING KENTâ??S REPERTORYâ??AN OPEN LABEL SINGLE ARMNON-RANDOMIZED CLINICAL TRIA

national institute of homoeopathy0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Patient having alternating symptom or alternating state of illness
  • 2)Both male and female
  • 3)All age groups
  • 4)Patients giving written consent to participate in the study.
  • 5)Patients who can read Hindi/Bengali/English.

Exclusion Criteria

  • 1)Patients unwilling to give consent
  • 2)Patient doesnâ??t have alternating symptom or alternating state of illness
  • 3)Patients having medical emergency
  • 4)Patients requiring surgical operation
  • 5)Pregnant and lactating women
  • 6)Patients undergoing homoeopathic treatment elsewhere
  • 7)Substance abuse and / or dependence

Investigators

Similar Trials